Uhmann, Anja <br/><br/>
DMBA/TPA treatment is necessary for BCC formation from patched deficient epidermal cells in Ptch(flox/flox)CD4Cre(+/-) mice.  [electronic resource] 

 -  The Journal of investigative dermatology  Oct 2014 
 - 2620-2629 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-1747 
<br/><br/><label>Standard No.: </label>10.1038/jid.2014.157  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>9,10-Dimethyl-1,2-benzanthracene--adverse effects<br/>Alleles<br/>Animals<br/>CD4-Positive T-Lymphocytes--pathology<br/>Carcinogenesis--chemically induced<br/>Carcinogens--pharmacology<br/>Carcinoma, Basal Cell--chemically induced<br/>Disease Models, Animal<br/>Epidermis--pathology<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Mice, Transgenic<br/>Mutation--genetics<br/>Patched Receptors<br/>Patched-1 Receptor<br/>Proto-Oncogene Proteins p21(ras)--genetics<br/>Receptors, Cell Surface--deficiency<br/>Signal Transduction--physiology<br/>Skin Neoplasms--chemically induced<br/>Stem Cells--pathology<br/>Tetradecanoylphorbol Acetate--adverse effects